Literature DB >> 2104877

A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.

E A Brinton1, S Eisenberg, J L Breslow.   

Abstract

Diets that reduce atherosclerosis risk lower levels of HDL cholesterol (HDL-C), but the significance of this is unclear. To better understand the mechanism of this phenomenon we studied the turnover of HDL apolipoproteins A-I and A-II in 13 subjects on two contrasting metabolic diets. Upon changing from high to low intake of saturated fat and cholesterol the mean HDL-C decreased 29% from 56 +/- 13 (SD) to 40 +/- 10 mg/dl, while apo A-I levels fell 23% from 139 +/- 22 to 107 +/- 22 mg/dl (both P less than 0.001). Mean apo A-II levels did not change. The fractional catabolic rate (FCR) of apo A-I increased 11% from 0.228 +/- 0.048 to 0.254 +/- 0.063 pools/d, while its absolute transport rate (TR) decreased 14% from 12.0 +/- 2.7 to 10.3 +/- 3.4 mg/kg per d (both P = 0.005). The decrease in HDL-C and apo A-I levels correlated with the decrease in apo A-I TR (r = 0.79 and 0.83, respectively; P less than 0.001), but not with the increase in apo A-I FCR (r = -0.04 and -0.02, respectively). In contrast, within each diet the HDL-C and apo A-I levels were inversely correlated with apo A-I FCR both on the high-fat (r = -0.85 and -0.77, P less than 0.001 and = 0.002, respectively) and low-fat diets (r = -0.67 and -0.48, P = 0.012 and 0.098, respectively) but not with apo A-I TR. In summary, diet-induced changes in HDL-C levels correlate with and may result from changes in apo A-I TR. In contrast, differences in HDL-C levels between people on a given diet correlate with and may result from differences in apo A-I FCR. Therefore, the mechanism of dietary effects on HDL levels differs substantially from the mechanism explaining the differences in levels between individuals on a fixed diet. In assessing coronary heart disease risk, it may be inappropriate to conclude that diet-induced decreases in HDL are equivalent to low HDL within a given diet.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104877      PMCID: PMC296399          DOI: 10.1172/JCI114405

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

2.  Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men from 13 countries.

Authors:  J T Knuiman; C E West; J Burema
Journal:  Am J Epidemiol       Date:  1982-10       Impact factor: 4.897

3.  In vivo metabolism of human apoprotein A-I-phospholipid complexes. Comparison with human high density lipoprotein-apoprotein A-I metabolism.

Authors:  C L Malmendier; C Delcroix; J P Ameryckx
Journal:  Clin Chim Acta       Date:  1983-07-15       Impact factor: 3.786

4.  Serum lipids and lipoproteins in insulin-dependent diabetic subjects during high-carbohydrate, high-fiber diet.

Authors:  M R Taskinen; E A Nikkilä; A Ollus
Journal:  Diabetes Care       Date:  1983 May-Jun       Impact factor: 19.112

5.  Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins.

Authors:  M Sorci-Thomas; M M Prack; N Dashti; F Johnson; L L Rudel; D L Williams
Journal:  J Lipid Res       Date:  1989-09       Impact factor: 5.922

7.  High density lipoprotein metabolism in man.

Authors:  C B Blum; R I Levy; S Eisenberg; M Hall; R H Goebel; M Berman
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

8.  High density lipoprotein metabolism in a rabbit model of hyperalphalipoproteinemia.

Authors:  D W Quig; D B Zilversmit
Journal:  Atherosclerosis       Date:  1989-03       Impact factor: 5.162

9.  Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.

Authors:  K Saku; P S Gartside; B A Hynd; S G Mendoza; M L Kashyap
Journal:  Metabolism       Date:  1985-08       Impact factor: 8.694

10.  The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects.

Authors:  E J Schaefer; R I Levy; N D Ernst; F D Van Sant; H B Brewer
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

View more
  47 in total

Review 1.  Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

Authors:  A R Tall
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

3.  Dietary unsaturated fat increases HDL metabolic pathways involving apoE favorable to reverse cholesterol transport.

Authors:  Allyson M Morton; Jeremy D Furtado; Carlos O Mendivil; Frank M Sacks
Journal:  JCI Insight       Date:  2019-04-04

Review 4.  Influence of dietary carbohydrate and fat on LDL and HDL particle distributions.

Authors:  Patty W Siri; Ronald M Krauss
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

5.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Healthy Heart, Healthy Family: a NHLBI/HRSA collaborative employing community health workers to improve heart health.

Authors:  Ritabelle Fernandes; Kathryn L Braun; Jovonni R Spinner; Cynthia Sturdevant; Sharonne J Ancheta; Sheryl R Yoshimura; Merlita Compton; Jo-Hsi Wang; Carolyn J Lee
Journal:  J Health Care Poor Underserved       Date:  2012-08

7.  apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes.

Authors:  L S Huang; E Voyiaziakis; D F Markenson; K A Sokol; T Hayek; J L Breslow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; D J Rader; T Sakamoto; M Nishiwaki; N Wakimoto; J R Schaefer; T Ishikawa; T Fairwell; L A Zech; H Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.

Authors:  Theodore W K Ng; Dick C Chan; P Hugh R Barrett; Gerald F Watts
Journal:  Clin Sci (Lond)       Date:  2009-10-02       Impact factor: 6.124

10.  Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.

Authors:  Kazuhiko Kotani; Naoki Sakane; Yoshiko Sano; Kokoro Tsuzaki; Yukiyo Matsuoka; Kahori Egawa; Makiko Yoshimura; Chika Horikawa; Yoshinori Kitagawa; Yoshinobu Kiso; Satoshi Kimura; John Schulze; Jennifer Taing; Alejandro Gugliucci
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.